Pharming (NASDAQ:PHAR) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.01 by 800 percent. This is a 68.18 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $72.400 million which missed the analyst consensus estimate of $93.750 million by 22.77 percent. This is a 8.47 percent decrease over sales of $79.100 million the same period last year.